Promega Ireland’s Post

Harness the effectiveness of Maxwell® instruments to advance your gene and cell therapy research. From mRNA expression analysis to transgene copy number assays, these tools are crucial for understanding gene expression across various samples and pivotal in the development of effective therapies. Maxwell® instruments stand as indispensable partners through every phase from R&D to clinical trials, handling diverse sample types with unmatched versatility. Step into the future of gene and cell therapy with Maxwell®. Discover more about how these instruments can transform your scientific discoveries. 👉 Explore our technologies: https://bit.ly/3WIC6wy #NucleicAcidExtraction #mRNA #transgene

Harness the effectiveness of Maxwell® instruments to advance your gene and cell therapy research. From mRNA expression analysis to transgene copy number assays, these tools are crucial for understanding gene expression across various samples and pivotal in the development of effective therapies. Maxwell® instruments stand as indispensable partners through every phase from R&D to clinical trials, handling diverse sample types with unmatched versatility. Step into the future of gene and cell therapy with Maxwell®. Discover more about how these instruments can transform your scientific discoveries. 👉 Explore our technologies: https://bit.ly/4e0t3gv #NucleicAcidExtraction #mRNA #transgene #Maxwell #PromegaTechnologies

Thanks to American Society of Gene & Cell Therapy and Citeline for putting together the Q4 #cellandgenetherapy landscape report. The report provides valuable insights into the current state of the cell, gene, and RNA therapy landscape. Check out the full report on asgct.org. #ASGCT #Citeline #biotech #healthcare #innovation

Potency #bioassays remain a hot topic for innovative cell and gene therapy drugs.💉Using our QC assays (flow cytometry, cell-based potency, automated imaging and analysis tools), we can determine your product’s: 🦠Delivery of transgene to cell 🧬Transgene expression 💉Successful translation into functional product This is essential at multiple stages of the product life cycle, including future clinical trials. Want to learn what #potencyassays can do for you? Book a call with our science team: https://buff.ly/3Q4D4A7 #celltherapy #genetherapy #bioassays #bioanalyticallab #bioanalysis #CGT

Immune rejection is a major drawback with any cell therapy. One way to overcome this is to interfere with the immune recognition properties of the therapeutic cell by gene editing. For example, the HLA 1 system can be modulated by knocking out the B2M gene, which controls recognition of the therapeutic cell by the immune system. To find out how our StemEdit Clinical Gene Editing can help your project: https://hubs.li/Q02mPY8W0

IQVIA’s latest white paper takes an exploratory deep dive into the next decade of cell, gene, and RNA therapies. With insightful contributions from IQVIA experts, join us on a journey of discovery as we step into a new era of pharmacotherapeutics. https://bit.ly/3HNgqXY #CAGT #pharmacotherapeutics

#Interview now available! Exploring the convergence of #geneediting and #RNAi in iPSC-derived #allogeneic cell therapy Within cell and #genetherapy, there is a growing reliance on innovation in #genomeediting technology. Read this interview with Vlad Seitan, (Chief Scientific Officer, Laverock Therapeutics) about enhancing advanced therapies through a novel approach that combines the power of gene editing with the #RNAinterference (RNAi) pathway. Read below:

If you're at the American Society of Gene & Cell Therapy meeting, stop by the Donaldson booth and learn about innovative technologies in #scaleup and #purification. Also, say hello to my teammates David Moccia, Matt Kremer, Corey Jacklin and Floriane Cohen for me! They call tell you all about our Scale-X platform and how it can help reduce cost and maximize efficiency in suspension and adherent workflows! #biorectors #bioprocess

Did you know that there are currently more than 4000 therapies in development? According to the American Society of Gene and Cell Therapies (ASGCT), there are currently over 4,000 #gene, #cell, and #RNA therapies in development. The ASGCT also noted significant increases in the number of therapies in all three phases of clinical pipeline development, with a notable 11% growth in Phase I programs. This significant development over the years shows promising cell and gene therapy trends. Want to know more about #cellandgenetherapy, join us at Advanced Therapies USA 👉 https://lnkd.in/eaBjYK3y #adtherapiesUSA #advancedtherapies

How can you be sure you're meeting regulatory standards for residual host cell DNA in your cell or gene therapy product? Find out here: https://lnkd.in/gVEf9acS HEK293 cells are a commonly used platform for cell and gene therapy production, but traces of DNA from these host cells can be a dangerous potential contaminant in therapeutic products. Droplet Digital PCR technology offers an efficient and sensitive approach for residual host cell DNA detection, enabling absolute quantification of nucleic acid contaminants. Bio-Rad's Vericheck ddPCR HEK293 Residual DNA Detection Kits support a user-friendly workflow for precise measurement of host cell DNA to ensure every product batch adheres to regulatory guidelines. Learn more: https://lnkd.in/grUJZFea #CellTherapy #GeneTherapy #QualityControl #ddPCR